Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.24%, DAX +0.63%, CAC40 +0.36%

Aug 05 ,2026

  • Synopsis

    • European equity markets are set for a higher open amidst higher Asian equities Wednesday. Semis/memory driving outperformance of Japan, Taiwan and South Korea. Gains picking up in mainland China indexes with chip stocks surging. Hong Kong little changed. S&P 500 futures advancing afterhours though SpaceX (SPCX) sold off post-earnings with capex attracting scrutiny.

    • Markets weighing latest sign of progress in negotiations to reopen Strait of Hormuz with crude down to lowest levels since early July. US and Iranian officials voiced hope for an agreement to break the deadlock with reported draft proposal seeing ships enter via Iran side of the Strait and exit via Oman side. Iran also said to be open to voluntary fee payment mechanism.

    • Back in Europe, Norway's minister of foreign affairs Eide and minister of fisheries and the oceans Næss meet the seafood industry about US tariffs at 12noon CET being joined by minister of trade, industry and fisheries Myrseth at 13:00CET. Release of Germany, Russia and UK Jul new car registrations are due for release. There's the expiry of offer period in connection with Brødrene A. & O. Johansen's (AOJ.B.DC) acquisition of Elektroimportøren (ELIMP.NO)

    • On the macro front, Italy, Spain, Sweden Jul services PMI and final reads for Eurozone, France, Germany, UK, France Jun industrial production, Eurozone Jun PPI and Portugal Q2 unemployment rate.

    • Earnings kicked off with Novo Nordisk (NOVO.B.DC) reporting Q2 earnings yesterday after market close and raising FY guidance whilst in the DACH region, Siemens Energy (ENR.GR), Fresenius (FRE.GR), DHL Group (DHL.GR), Infineon Technologies (IFX.GR) and Sandoz (SDZ.SW) updated investors. Elsewhere, Heineken (HEIA.NA) and Ahold Delhaize (AD.NA) are also out with results while Cenergy Holdings (CENER.BB) also raised its FY guidance.

    • Also due to report today are BPER Banca (BPE.IM), Banco BPM (BAMI.IM), Wolters Kluwer (WKL.NA), Glencore (GLEN.LN), Coca-Cola HBC (CCH.LN), Legal & General Group (LGEN.LN) and Beazley (BEZ.LN).

  • Politics/Macro/World News

    • Negotiators near interim deal to reopen Strait of Hormuz for 60 days with no fees or tolls - Axios

  • Top company news

    • Earnings/updates

      • Benelux:

        • HEIA.NA (Heineken) -- reports H1 EPS (beia) €2.29 vs consensus €2.28; reiterates FY operating profit guidance

        • AD.NA (Ahold Delhaize) -- reports Q2 EPS €0.63 ex-items vs consensus €0.63

        • CENER.BB (Cenergy Holdings) -- reports Q2 net income attributable €63.7M vs FactSet €54.2M [1 est]; raises FY adjusted EBITDA guidance

      • DACHs:

        • ENR.GR (Siemens Energy) -- reports Q3 EPS €1.28 vs FactSet €1.17 [6 est, €1.10-1.22]; confirms FY26 outlook

        • FRE.GR (Fresenius) -- reports Q2 core EPS €0.83 vs consensus €0.80

        • DHL.GR (DHL Group) -- reports Q2 EPS €0.90 vs FactSet €0.92 [6 est, €0.76-1.01]; EBIT in line with prelims; share buyback program increased and extended

        • IFX.GR (Infineon Technologies) -- reports Q3 adj EPS €0.44 vs consensus €0.44; guides Q4 and FY26

        • SDZ.SW (Sandoz Group) -- reports H1 EPS $1.71 vs FactSet $1.74 [2 est, $1.70-1.77]

        • TIMA.GR (ZEAL Network) -- reports Q2 EPS €0.64 vs year-ago €0.46

        • LNZ.AV (Lenzing) -- reports H1 net income €35.6M vs year-ago €15.2M; Q2 revenues and EBITDA in line with 27-Jul prelims

        • ZIL2.GR (Elringklinger) -- reports Q2 EPS €0.18 vs year-ago (€0.15); FY26 guidance and medium-term targets confirmed

        • KCO.GR (Kloeckner & Co.) -- reports Q2 adjusted EBITDA €63M vs FactSet €67.5M [2 est, €67-68M]

        • SHA0.GR (Schaeffler) -- reports Q2 EBIT €264M vs consensus €266.0M; reaffirms FY guidance

        • 6LL.GR (Lime) -- reports Q2 EPS $4.73 vs year-ago $0.71

        • BSL.GR (Basler) -- reports H1 net income €23.6M vs year-ago €6.4M

        • RSGN.SW (R&S Group Holding) -- reports preliminary H1 net sales CHF179.2M vs FactSet CHF192.1M [3 est, CHF181.4-206M]

        • SPG.GR (Springer Nature) -- reports H1 net income attributable €101.3M vs FactSet €99M [1 est]

      • Nordics:

        • NOVO.B.DC (Novo Nordisk) -- reports Q2 EPS DKK6.18 ex-items vs consensus DKK5.00

        • RILBA.DC (Ringkjøbing Landbobank) -- raises FY net income guidance

        • STRAP.DC (Strategic Partners) -- reports H1 EPS DKK24.00 vs year-ago (DKK28.00); confirms FY outlook

        • HKFOODS.FH (HKFoods) -- reports Q2 comparable EPS €0.02 vs FactSet €0.03 [2 est, €0.02-0.05]

        • ORRON.SS (Orrön Energy) -- reports Q2 net income from continuing operations (€1.2M) vs FactSet (€5.8M) [2 est, (€5.5)-(4.7M)]

        • RILBA.DC (Ringkjøbing Landbobank) -- reports Q2 net income DKK609M vs FactSet DKK584.6M [5 est, DKK568-600M]

      • Southern Europe:

        • DAL.IM (Datalogic) -- reports Q2 net income €2.3M vs year-ago restated €5.1M

        • ICOS.IM (Intercos) -- reports Q2 adjusted EBITDA €47.5M vs FactSet €46.0M [2 est, €46-46M]; reaffirms FY current consensus on net sales is within its original guidance range

        • MARR.IM (Marr) -- reports H1 net income attributable €3.9M vs FactSet €5.2M [2 est, €2.3-8M]

        • SFL.IM (Safilo Group) -- reports Q2 adjusted EBITDA €49.0M incl. items and unclear if comparable to FactSet €27.4M [4 est, €26-28.3M]

        • CE.IM (Credito Emiliano) -- reports Q2 net income €139.5M vs FactSet €137.6M [5 est, €135-142M]

    • M&A

      • JST.GR (JOST) -- to divest Hyva's Tipper Body Business in India to Belrise Industries for about €5M; confirms its outlook for 2026

      • ANTIN.FP (Antin) -- has entered into exclusive negotiations with the Infrastructure Investments Fund for the sale of Idex

      • JPM (JPMorgan Chase) -- nearing deal to acquire Idex from Antin Infrastructure Partners - Bloomberg

      • U11.SP (United Overseas Bank Ltd. (Singapore)) -- United Overseas Bank Ltd. to sell UOB Asset Management to Allianz Global Investors for SG$555M cash

      • RIO.AU (Rio Tinto) -- sale process for its Infrastructure assets getting closer to launch, expected value A$2-3B ($1.4-2.1B) -- The Australian

      • WBS (Webster Financial) -- Banco Santander receives Federal Reserve approval for previously announced acquisition of Webster Financial Corporation

      • CTY1S.FH (Citycon) -- Oyj announces preliminary result of G City Ltd.'s voluntary public cash tender offer for all outstanding shares in Oyj

      • CY5.AU (Cygnus Metals) -- issues update on scheme with Central Asia Metals; North Macedonian merger clearance condition precedent satisfied

      • FTC reviewing merger between Covetrus and MWI Animal Health - Bloomberg

    • Healthcare

      • BAYN.GR (Bayer AG) -- NICE recommends Bayer's Kerendia to treat chronic heart failure with preserved or mildly reduced ejection fraction

    • Other

      • BSLN.SW (Basilea Pharmaceutica) -- receives additional $5.4M from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

      • TPEIR.GA (Piraeus Bank) -- announces the payment of previously disclosed €0.40/share capital return will now take place from 5-Aug

  • Key rating changes

    • Upgrades

      • GXI.GR (Gerresheimer) -- to neutral from sell at UBS

      • NEX.FP (Nexans) -- to overweight from neutral at JPMorgan

      • PNDORA.DC (Pandora) -- to buy from hold at ABG Sundal Collier

    • Downgrades

      • SN.LN (Smith & Nephew) -- to underweight from equal weight at Barclays

      • BBVA.SM (Banco Bilbao Vizcaya Argentaria) -- to hold from buy at Deutsche Bank

      • ROR.LN (Rotork) -- to sector perform from outperform at RBC Capital Markets

      • DANSKE.DC (Danske Bank) -- to neutral from buy at Sparebank 1 Markets (4-Aug, timing uncertain)

    • Initiations

      • OHB.GR (OHB SE) --

        • neutral at Goldman Sachs

        • buy at Jefferies

        • buy at Berenberg

  • Data

    • Nikkei +3.58% to 66245.32

    • Hang Seng +0.19% to 25900.89

    • Shanghai Composite +1.51% to 3880.02

    • S&P futures +31.5 vs prior close of 7765.5

    • €-$ +0.0006 or +0.05% to 1.1538

    • $-¥ (0.09) or (0.05%) to 157.65

    • €-¥ (0.02) or (0.01%) to 181.87

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.